Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model  by Chaufour, Xavier et al.
During the last 15 years, angioscopy has become
a valuable clinical tool in vascular surgery,1,2 both for
diagnosis3,4 and treatment.5,6 Despite its widespread
use, the rate of complications reported after angio-
scopy is less than 1%.2 Angioscopes are either inte-
gral (single) or separate (multiple) units. In separate
units, fiberoptics and lenses are interchangeable and
either are able to be sterilized or are disposable.
Integral units offer better optics because the lenses
and fiberoptics are ideally aligned, but they are more
delicate to handle and more expensive than separate
units. Most of the integral units can be sterilized.
The high initial cost of reusable angioscopes and the
ongoing purchase cost of disposable units are pre-
venting the use of angioscopes in many vascular
surgery units.
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Purpose: Nosocomial transmission of viral hepatitis and retrovirus infection has been
reported. The expected risk is greatest for the hepatitis B virus (HBV). The duck HBV
(DHBV) has similar biologic and structural characteristics to HBV and has been adopt-
ed as a suitable model for disinfectant testing.
Methods: Angioscopic examination of the external jugular vein was performed on DHBV-
infected ducks. After use, the instrument was air dried for 3 minutes. Samples were
obtained by flushing the channel with 5 mL of phosphate buffered saline solution. The
samples were collected immediately after drying (control), after flushing with 5 mL of
water, after glutaraldehyde disinfection for 5, 10, and 20 minutes, and after ethylene
oxide gas sterilization. Angioscopes were either precleaned or uncleaned before disinfec-
tion/sterilization. Residual infectivity was assessed with inoculation of samples into the
peritoneal cavity of day-old ducks (n = 231).
Results: DNA analysis results of liver samples showed that all 38 control ducks became
infected. The frequency of DHBV infection was reduced to 93% (14 of 15) by flushing the
angioscope with 5 mL of sterile water. No transmission occurred after the use of any of the
properly precleaned and disinfected/sterilized angioscopes. However, after the use of the
uncleaned angioscopes, the transmission rate was 90% (9 of 10) and 70% (7 of 10) after 5
and 10 minutes of contact time, respectively, in 2% glutaraldehyde. Even after the recom-
mended 20 minutes of contact time, there was still 6% (2 of 35) transmission. After ethyl-
ene oxide sterilization, two of the recipient ducklings (2 of 35) were infected with DHBV.
Conclusion: There was no disease transmission after reuse of disposable angioscopes ade-
quately cleaned before disinfection or sterilization. However, if the angioscopes are inad-
equately cleaned, DHBV can survive despite glutaraldehyde disinfection or ethylene
oxide sterilization. This contrasts with previous in vitro and in vivo data with solid sur-
gical instruments. It is postulated that the presence of a narrow lumen or residual pro-
tein shielding within the lumen may compromise effective inactivation of hepadnavirus-
es on angioscopes, with the potential risk for patient-to-patient transmission. (J Vasc
Surg 1999;30:277-82.)
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The reuse of disposable angioscopes would great-
ly decrease the cost of angioscopy. However, the
potential risks of nosocomial transmission of viral
hepatitis and retrovirus infection must be considered.
The expected risk of disease transmission is greatest
for the hepatitis B virus (HBV) because of its high
level of viremia and its large numbers of chronic car-
riers.7 HBV has been transmitted by contaminated
medical devices used in diagnostic8 and therapeutic
procedures.9 Infection control guidelines suggest
that instruments, materials, and medications must be
clean and sterile when introduced into normally ster-
ile tissues. Sterility can be achieved by steam steriliza-
tion under pressure, dry heat, radiation, ethylene
oxide, or chemical treatment. Sterilization destroys
all microorganisms, including spores, and disinfec-
tion eliminates all vegetative organisms but does not
ensure the elimination of all spores.10
Although the effectiveness of current disinfectants
and chemical sterilants against bacterial pathogens has
been extensively studied, the inactivation of viruses is
more difficult to evaluate. Even with those viruses
used for regulatory purposes that have infectivity
assays in cell culture, it is difficult to show reduction
in titers of 104 or more because of the inherent toxi-
city of the disinfectant for the cultured cells. The duck
hepatitis B virus (DHBV) has been shown to have
similar biologic and structural characteristics to
HBV.11 On the basis of electron microscopic mor-
phology polymerase activity and limited chimpanzee
transmission studies, DHBV and HBV have similar
inactivation kinetics.12,13 With the duck model, it is
possible to show greater than a 106 reduction in viral
titer because DHBV reaches high titers of virus in the
blood and baby ducks are sensitive to the infection.14
Because of these advantages, the DHBV model has
been accepted by regulatory authorities as a surrogate
virus for HBV in the testing of disinfectant efficacy for
registration.15
There are little data available on disinfection and
sterilization of angioscopes, and the manufacturers
recommendations of 2% glutaraldehyde disinfection
or ethylene oxide sterilization appear to have been
extrapolated from studies conducted on gastroin-
testinal endoscopes and laparoscopes. In turn, these
recommendations were made on the basis of in vitro
data extrapolated from studies of other viral classes16
and limited animal studies with the chimpanzee
model.17 Factors relating to instrument use, such as
shape, composition, and presence of shielded areas
(eg, lumens), have not been taken into account and
may lead to failure of adequate disinfection and sub-
sequent nosocomial infection. Furthermore, the cri-
teria for reduction in microbial viability required by
regulating authorities (greater than 104 reduction in
microbial count) do not necessarily equate with
complete loss of infectivity.18
In this study, we aimed to analyze the risk of
nosocomial infection after the reuse of disposable
angioscopes that were either properly or inadequate-
ly cleaned before disinfection/sterilization proce-
dures. In addition, we established a method to test
the ability of 2% glutaraldehyde and ethylene oxide
gas to inactivate DHBV-contaminating angioscopes.
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Fig 1. Testing protocol.
MATERIALS AND METHODS
Experimental animals
Pekin cross Aylesbury crossbred ducks were
obtained from a commercial supplier. All the exper-
imental work was approved by the University of
Sydney Animal Ethics Committee and complied
with the Guide for the Care and Use of Laboratory
Animals. Ducklings were obtained from DHBV-
negative flocks, and serum samples that were taken
before surgery were shown to be DHBV DNA free.
Source ducks. An aliquot (100 uL) of DHBV-
positive serum was inoculated into the peritoneum
of seven 1-day-old ducklings. These animals were
used at 3 to 4 weeks of age to represent the “bio-
hazardous” patient.
Angioscopes
Thirteen disposable angioscopes were tested: four
Edwards LIS (size, 2.3 mm; Baxter Healthcare, Irvine,
Calif) and six Intramed PF 28 (size range, 1.5 mm to
2.8 mm; Intramed, San Diego, Calif). The character-
istics of the different angioscopes are described in
Table I. All the angioscopes were single channeled.
Experimental protocol (Fig 1)
The source duck was premedicated with 1 mg/kg
of ketamine hydrochloride intramuscularly. Anesthesia
induction and maintenance was with halothane (ICI
Pharmaceuticals, Cheshire, United Kingdom). The
animals were shaved and surgically prepared with 
70% ethanol and povidone-iodine (Faulding Pharma-
ceuticals, Salisbury, South Australia). Intravenous
heparin therapy, 100 IU/kg (heparin sodium, Delta
West, Bently, Western Australia), was given every 90
minutes to prevent coagulation. Source duck blood
contained between 105.5 and 107 50% infectious dose
day-old duckling doses of DHBV/mL.
The right external jugular vein was exposed and
controlled with vessel loops. A transversal venotomy
was made in the jugular vein, and a sterilized angio-
scope was fed into the right atrium of the heart. A
small amount of blood was aspirated to ensure con-
tamination of the entire channel. The angioscope
was left in situ for 3 minutes. The angioscope then
was removed and subjected to one of the following
treatments:
1. No disinfection (control group: n = 38).
2. Water wash in which angioscopes were flushed
with 5 mL of sterile water (n = 15).
Improperly cleaned angioscopes. The angio-
scopes were not washed in detergent or brushed but
were flushed once with 5 mL of sterile water before:
3. Glutaraldehyde disinfection in which the angio-
scopes were flushed with 5 mL of glutaraldehyde
and then soaked in 2% glutaraldehyde (Aidal
Plus, Whiteley Industries Ltd, Sydney, Australia)
for 5 minutes (n = 10), 10 minutes (n = 10), or
20 minutes (n = 35).
4. Ethylene oxide sterilization in which the angio-
scopes were flushed with 5 mL of sterile water,
dried, and sterilized with ethylene oxide gas (eth-
ylene oxide gas dwell time, 6 hours at 50˚C, and
chamber pressure of 70 kpa, followed by aeration
of 18 hours). Each sterilization cycle included a
technical readout of the physical parameters
encountered and was monitored with Bacillus
spp spore kits as biologic indicators (n = 35).
Properly cleaned angioscopes. All the angio-
scopes were placed in a sink full of clean tap water.
External debris were removed with gauze, and the
lumen was flushed with 40 mL of water. Angioscopes
were placed in warm water that contained a deter-
gent (Medizyme, Whiteley Industries Ltd) and were
flushed with 20 mL of the detergent mix. The lumen
was brushed with a cleaning brush and re-flushed
with another 20 mL of detergent mix before soaking
for 10 minutes. The angioscopes then were rinsed
and flushed (40 mL) with water before:
5. Glutaralderhyde disinfection in which angio-
scopes were soaked in 2% glutaraldehyde (Aidal
Plus, Whiteley Industries Ltd) for 5 minutes (n =
10), 10 minutes (n = 10), or 20 minutes (n = 35)
and re-flushed with 40 mL of sterile water and
dried with an air gun.
6. Ethylene oxide sterilization in which the angio-
scopes were dried with an air gun and sterilized
with ethylene oxide gas using the same condi-
tions as previously (n = 33).
At the completion of surgery, the source animals
were killed with a lethal injection of pentobarbitone
sodium (325 mg/mL). After disinfection/steriliza-
tion, samples were collected by flushing the angio-
scope channel with 5 mL of phosphate buffered
saline solution. An aliquot (100 uL) of each sample
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Table I. Characteristics of angioscopes used
Channel Usable Field of
Manufacturer diameter (mm) No. length (cm) view (degrees)
Edward LIS 2.3 4 80 70
Intramed 1.5 1 100 72
1.9 1 100 72
2.3 4 70 72
2.5 2 70 72
2.8 1 80 72
All angioscopes were single channeled and disposable.
was injected into the peritoneal cavity of a 1-day-old,
DHBV-negative duckling (one duck per sample, 
n = 231).
Detection of DHBV DNA
The experimental animals were killed 14 days
after operation, at which time livers were harvested
for DHBV DNA analysis. Liver samples (0.2 cm3)
were proteinase K digested and phenol chloroform
extracted. Extracted liver DNA and serum then were
spotted onto a nylon membrane and hybridized with
P32-labeled DHBV DNA, washed, and autoradi-
ographed as previously described.19
RESULTS
All the ducklings were found to be DHBV neg-
ative on day of hatching and before inoculation. The
mortality rate of recipient ducklings was 0%.
There was no transmission of DHBV to recipient
ducklings after correct washing and disinfection/ster-
ilization of angioscopes, but all ducklings in the con-
trol group (n = 38) that received samples from
unwashed angioscopes became DHBV DNA positive.
Even when the contact time in 2% glutaraldehyde was
reduced to only 5 minutes, transmission of DHBV
did not occur. The frequency of DHBV infection was
reduced to 93% (14 of 15) by flushing the angioscope
with 5 mL of sterile water. When angioscopes were
not washed and brushed in detergent before disinfec-
tion or sterilization procedures, DHBV was transmit-
ted to some recipient ducklings. Even so, transmission
was only 6% (2 of 35) after 20 minutes of contact time
with 2% glutaraldehyde. Decreasing exposure to glu-
taraldehyde increased the transmission rate to 70% (7
of 10) and 90% (9 of 10) for 10-minute and 5-minute
contact times, respectively. Surprisingly, after ethylene
oxide sterilization of improperly cleaned angioscopes,
6% (2 of 35) of the recipient ducklings also became
infected with DHBV.
DISCUSSION
In this study, we simulated patient-to-patient
transmission of hepadnavirus after the reuse of dis-
posable angioscopes. If properly cleaned before dis-
infection or sterilization, the reuse of disposable
angioscopes did not result in the transmission of
DHBV. However, DHBV was able to survive in the
channel of improperly decontaminated angioscopes
and was transmitted to susceptible hosts.
The angioscopes in this study were heavily cont-
aminated with DHBV blood that contained 105.5 to
107 50% infectious dose doses for day-old ducklings.
In practice, blood is rarely aspirated through the
angioscope channel. However, reflux of blood
sometimes occurs during extended procedures. In
addition, the contaminated angioscopes are often
left unwashed for long periods of time until all
patient procedures are completed.
Not unexpectedly, infection was transmitted to
all animals that received samples from unwashed
angioscopes. Flushing the angioscope with 5 mL of
sterile water before collecting the samples reduced
the viral load sufficiently to enable one duck of 15 to
escape infection (93%).
Despite the heavy contamination with DHBV, if
the angioscopes were properly washed and brushed
in detergent before glutaraldehyde disinfection, then
no transmission of DHBV occurred, even if the dis-
infectant contact time was reduced to 5 minutes.
However, if the angioscopes were not washed and
brushed in detergent, then even a 20-minute con-
tact time with 2% glutaraldehyde failed to complete-
ly inactivate DHBV and transmission occurred in 6%
of cases. The shorter contact times led to higher
rates of failure. Similarly, ethylene oxide sterilization
also failed to inactivate DHBV in 6% (2 of 35) of the
cases, despite the inactivation of the biologic indica-
tor and adequate gas dwell time, temperature, and
pressure. The failure of both ethylene oxide and glu-
taraldehyde to inactivate DHBV may be the result of
the high biologic burden that is encountered inside
these improperly cleaned angioscopes. Organic mat-
ter interferes with the antimicrobial action of all
chemical disinfectants and sterilants to some degree.
This interference is caused by a reaction between the
compound and the organic matter, which leaves less
agent for attacking microorganisms, or is caused by
the physical protection of microorganisms that pre-
vents disinfectant/sterilant access. Ethylene oxide
access is also reduced if the instruments are not dried
sufficiently, although over-drying that causes the
dehydration of microorganisms reduces their suscep-
tibility to ethylene oxide sterilization.20
Currently, glutaraldehyde is the only chemical
that is recommended10 for the high-level disinfec-
tion of reuseable items that cannot be heat sterilized.
Twenty minutes of immersion in 2% glutaraldehyde
will normally kill all the vegetative organisms that
contaminate carriers, which are clean and free of
organic material.21 Several studies have documented
the sensitivity of HBV13,22 and DHBV12,18 to glu-
taraldehyde in vitro, with complete inactivation
occurring in less than 2.5 minutes.18 Ethylene oxide
is considered to be a sterilant and has been shown to
inactivate all types of microorganisms, including
endospores and viruses.20 Its inactivating effect is
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thought to be the result of alkylation of protein.
However, inactivation of a virus in vitro may not
directly correlate with inactivation of the same virus
on instruments in practice. This may be caused by
the protective factors within whole blood or the
interaction of blood and viral proteins with instru-
ment surfaces to prevent uniform access of the dis-
infectant/sterilant. We have previously shown that
the glutaraldehyde inactivation of DHBV in whole
blood that contaminated uncleaned laparoscopes19
took twice as long as expected from in vitro studies
that involved virus suspended in serum18 (5 minutes
vs 2.5 minutes). In comparison, a 20-minute contact
time was insufficient to inactivate DHBV that cont-
aminated the improperly cleaned angioscopes. We
propose that the difference between the results
obtained with laparoscopes and angioscopes is relat-
ed to instrument shape or material.
Decontamination of instruments is a two-phase
operation. Initial cleaning serves to reduce the
microbial load and to reduce the biologic load, which
may interfere with the disinfectant/sterilant action.
This is followed by the killing of residual microbes on
the clean instruments by the disinfectant/sterilant. In
this study, we investigated the effect of precleaning
on subsequent disinfectant/sterilant action. The
worst case scenario—that of heavily contaminated
instruments improperly or minimally cleaned—was
represented by the improperly cleaned angioscopes.
In these angioscopes, microbial numbers and biolog-
ic load were not decreased by use of a normal clean-
ing protocol, and transmission of DHBV occurred
despite adequate disinfection/sterilization protocols.
Normal cleaning protocol was followed in the prop-
erly cleaned angioscope groups where the channel
was flushed with a large volume of water and deter-
gent and was brushed, thereby removing a greater
proportion of the biologic burden and reducing the
risk of nosocomial infection. This is what should
happen in practice. Unfortunately, a visual inspection
cannot be made of these small channels to ensure
adequate cleaning has been achieved.
We found no correlation between channel diame-
ter and transmission of DHBV in the uncleaned angio-
scopes. However, the difficulty of flushing and brush-
ing the channel increased with the decreasing angio-
scope diameter. The greater the difficulty in cleaning,
the greater the risk of noncompliance of cleaning pro-
tocols. The problem can only increase in magnitude
with the development of highly flexible and smaller
diameter fibreoptics, which permit smooth navigation
of curving vessels but present channels that are even
more difficult to clean and sterilize.
We have attempted to address these issues by
establishing a disinfectant/sterilant assessment proto-
col to test residual infectivity after instrument decon-
tamination. Under the conditions of this study, prop-
er cleaning followed by disinfection/sterilization of
angioscopes prevented disease transmission and inad-
equate cleaning resulted in disease transmission
despite suitable disinfecting/sterilizing protocol.
These findings emphasize the necessity of following
decontamination protocols and the use of properly
trained personnel.
The longer time necessary to inactivate DHBV
in vivo as compared with the in vitro inactivation
warns against extrapolation of data on the basis of in
vitro studies to use in clinical practice. This has
important implications for the development of
guidelines for the decontamination and reuse of dis-
posable angioscopes and other instruments that
include a hollow channel by regulatory authorities.
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